J B Chemicals and Pharmaceuticals Complete Financial Statements
In FY2026, J B Chemicals and Pharmaceuticals (JBCHEPHARM) reported revenue ₹916 Cr, net profit ₹101 Cr and EPS ₹6.35, with a net profit margin of 11.0% and ROE of 2.4%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review JBCHEPHARM P/E comparison to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
JBCHEPHARM Revenue, Net Profit & EBITDA — Year-on-Year Growth
JBCHEPHARM YoY (Mar 2025 vs Mar 2026) — revenue -5.0%, net profit -30.8%, EBITDA -22.8%, expenses +1.0%. For live price, earnings ratios and company overview, see J B Chemicals and Pharmaceutic share price chart.
JBCHEPHARM Income Statement — Revenue, EBITDA & Net Profit
J B Chemicals and Pharmaceuticals revenue ₹916 Cr, EBITDA ₹186 Cr, net profit ₹101 Cr, EPS ₹6.35 (2026) — net profit margin 11.0%. Explore JBCHEPHARM value investing to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 916 | 1,100 | 964 | 1,109 | 1,083 | 1,011 | 878 | 1,010 | 972 | 889 | 767 | 902 | 852 | 811 | 627 | 786 | 796 | 613 | 554 | 619 | 605 | 452 | 447 | 545 | 604 | 475 | 435 | 459 | 445 | 444 | 408 | 398 |
| Expenses | 730 | 775 | 723 | 793 | 769 | 730 | 664 | 724 | 709 | 638 | 599 | 664 | 621 | 625 | 500 | 612 | 618 | 466 | 405 | 442 | 473 | 334 | 362 | 367 | 377 | 356 | 353 | 350 | 339 | 354 | 326 | 304 |
| EBITDA | 186 | 325 | 241 | 315 | 314 | 281 | 215 | 286 | 263 | 251 | 168 | 238 | 231 | 186 | 127 | 174 | 178 | 146 | 149 | 177 | 133 | 119 | 85 | 178 | 227 | 119 | 81 | 109 | 106 | 90 | 82 | 94 |
| Operating Profit Margin % | 19.00% | 29.00% | 24.00% | 28.00% | 28.00% | 27.00% | 23.00% | 28.00% | 26.00% | 28.00% | 21.00% | 26.00% | 26.00% | 23.00% | 20.00% | 22.00% | 22.00% | 21.00% | 23.00% | 27.00% | 21.00% | 25.00% | 18.00% | 30.00% | 31.00% | 22.00% | 16.00% | 22.00% | 21.00% | 19.00% | 20.00% | 20.00% |
| Depreciation | 50 | 44 | 46 | 43 | 45 | 42 | 41 | 41 | 42 | 32 | 32 | 31 | 34 | 28 | 22 | 26 | 28 | 16 | 17 | 18 | 17 | 18 | 17 | 17 | 17 | 16 | 12 | 16 | 17 | 15 | 15 | 15 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 | 9 | 6 | 3 | 10 | 14 | 12 | 13 | 8 | 2 | 6 | 8 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 135 | 279 | 193 | 272 | 267 | 237 | 165 | 240 | 218 | 209 | 123 | 194 | 184 | 150 | 103 | 142 | 141 | 129 | 132 | 158 | 114 | 99 | 67 | 157 | 209 | 102 | 68 | 92 | 88 | 75 | 66 | 78 |
| Tax | 33 | 71 | 47 | 69 | 69 | 62 | 38 | 63 | 56 | 58 | 35 | 52 | 50 | 39 | 18 | 37 | 35 | 32 | 31 | 39 | 30 | 25 | 17 | 38 | 54 | 8 | 22 | 30 | 22 | 23 | 21 | 28 |
| Net Profit | 101 | 208 | 146 | 202 | 198 | 175 | 126 | 177 | 163 | 151 | 88 | 142 | 134 | 111 | 85 | 105 | 106 | 98 | 101 | 119 | 84 | 74 | 50 | 120 | 154 | 94 | 47 | 62 | 66 | 52 | 46 | 50 |
| Earnings Per Share (₹) | 6.35 | 13.29 | 9.36 | 12.99 | 12.63 | 11.24 | 8.22 | 11.39 | 10.46 | 9.72 | 11.33 | 9.20 | 8.62 | 14.37 | 10.98 | 13.59 | 13.72 | 12.65 | 13.02 | 15.38 | 10.85 | 9.55 | 6.30 | 15.45 | 19.94 | 11.67 | 5.68 | 7.73 | 8.26 | 6.14 | 5.46 | 6.07 |
JBCHEPHARM Balance Sheet — Assets, Liabilities & Shareholders' Equity
JBCHEPHARM total assets ₹4,969 Cr, total equity ₹4,159 Cr, total liabilities ₹ Cr (2026) — ROE 2.4%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 4,969 | 4,274 | 3,994 | 3,554 | 2,607 | 2,238 | 1,821 | 1,792 | 1,765 | 1,674 | 1,648 | 1,487 |
| Current Assets | 2,909 | 1,923 | 1,853 | 1,528 | 1,253 | 1,553 | 1,073 | 1,051 | 1,047 | 795 | 816 | 901 |
| Fixed Assets | 1,902 | 1,968 | 2,004 | 1,901 | 1,277 | 634 | 651 | 621 | 640 | 679 | 440 | 329 |
| Capital Work in Progress | 61 | 63 | 76 | 55 | 19 | 26 | 16 | 15 | 17 | 4 | 135 | 55 |
| Investments | 683 | 345 | 388 | 206 | 13 | 678 | 403 | 457 | 434 | 411 | 479 | 367 |
| Other Assets | 0 | 1,897 | 1,525 | 1,392 | 1,299 | 901 | 750 | 699 | 674 | 580 | 594 | 737 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 218 | 208 | 203 | 519 | 85 | 79 | 69 | 65 | 46 | 27 | 31 | 33 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 4,159 | 3,433 | 2,923 | 2,480 | 2,139 | 1,813 | 1,438 | 1,483 | 1,444 | 1,366 | 1,186 | 995 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 4,143 | 3,418 | 2,908 | 2,465 | 2,119 | 1,794 | 1,420 | 1,464 | 1,425 | 1,347 | 1,167 | 978 |
JBCHEPHARM Cash Flow Statement — Operating, Investing & Financing
J B Chemicals and Pharmaceuticals operating cash flow ₹903 Cr, investing ₹-296 Cr, financing ₹-580 Cr, net cash flow ₹27 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 903 | 801 | 626 | 170 | 315 | 276 | 194 | 123 | 201 | 140 | 127 |
| Investing Activities | -296 | -404 | -962 | 2 | -231 | 24 | -28 | -21 | -45 | -26 | -112 |
| Financing Activities | -580 | -386 | 357 | -138 | -87 | -306 | -156 | -60 | -184 | -100 | -1 |
| Net Cash Flow | 27 | 11 | 20 | 34 | -3 | -6 | 11 | 43 | -28 | 15 | 13 |